You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 27 No. 3, September 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Role of Antidepressants and Neuroleptics in the Treatment of Depression

George M. Simpson, MB, ChB, MRC Psych; Mohammed Amin, MB, BCh, FRCP(C); J. W. Scott Angus, MB, Bch, MRC Psych, FRCP(C), DPM; J. Guy Edwards, MB, Bch, MRC Psych, DPM; S. Hing Go, MD; J. Hillary Lee, PhD

Arch Gen Psychiatry. 1972;27(3):337-345.


Abstract

In two studies, the relationship among depressive symptoms, depression, and psychotropic drugs was examined. In the first study, imipramine hydrochloride was administered in low and high dosages to chronic schizophrenic patients with prominent apathy and anergy, viz, symptoms of depression. Stimulating properties (improvement in areas of motor retardation and emotional withdrawal, worsening in tension) were noted. Not all patients displayed signs of stimulation; no suppression of the stimulative effect occurred with high dosages. The hypothesis that thiothixene might have a stimulative effect at low dosages in the above patients was not supported.

In the second study, thiothixene was compared with amitriptyline hydrochloride in the treatment of 40 patients who had been diagnosed as suffering from endogenous depression. Global ratings and rating scales favored amitriptyline. These results suggest that antidepressants are the treatment of choice in the diagnosis of depression, but they are probably contraindicated in symptoms of depression.



Author Affiliations

Orangeburg, NY

From the Early Clinical Drug Evaluation Unit, Research Center, Rockland State Hospital, Orangeburg, NY.


Footnotes

Accepted for publication March 30, 1972.

Reprint requests to Research Center, Rockland State Hospital, Department of Mental Hygiene, Orangeburg, NY 10962 (Dr. Simpson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials
BARBUI and HOTOPF
Br. J. Psychiatry 2001;178:129-144.
ABSTRACT | FULL TEXT  

Use of Antidepressant Drugs in Schizophrenia
Siris et al.
Arch Gen Psychiatry 1978;35:1368-1377.
ABSTRACT  

Overview of Recent Research in Depression: Integration of Ten Conceptual Models Into a Comprehensive Clinical Frame
Akiskal and McKinney
Arch Gen Psychiatry 1975;32:285-305.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.